Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and fever, particularly in conditions such as menstrual pain, arthritis, and mild to moderate acute pain. It belongs to the fenamate class of NSAIDs and works by inhibiting the production of prostaglandins, the chemicals responsible for pain and inflammation. Mefenamic Acid was developed in the 1960s by Parke-Davis and was approved for medical use, including regulatory approval on January 1, 1982 in certain markets. Since its introduction, it has been widely prescribed worldwide for short-term pain management and remains a commonly used medication due to its proven efficacy and established safety profile when used as directe